05-19179. National Cancer Institute; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the President's Cancer Panel.

    The meeting will be open to the pubic as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    Name of Committee: President's Cancer Panel.

    Date: October 24, 2005.

    Open: October 24, 2005, 8 a.m. to 5 p.m.

    Agenda: Strategic Planning-Translating Research Team Science/Clinical Research/Infrastructure Needs.

    Place: Hotel Washington, 15th and Pennsylvania Ave., NW., Washington, DC 20004.

    Contact Person: Abby Sandler, PhD, Executive Secretary, National Cancer Institute, National Institutes of Health, Building 6116, Room 212, 6116 Executive Boulevard, Bethesda, MD 20892, 301-451-9399.

    Any interested person may file written comments with the committee by forwarding the comments to the Contact Person listed on this notice. The comments should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute's/Center's home page: deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an agenda and any additional information for the meeting will be posted when available.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

    Start Signature

    Dated: September 16, 2005.

    Anthony M. Coelho, Jr.,

    Acting Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 05-19179 Filed 9-26-05; 8:45am]

    BILLING CODE 4140-01-M

Document Information

Comments Received:
0 Comments
Effective Date:
10/24/2005
Published:
09/27/2005
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
05-19179
Dates:
October 24, 2005.
Pages:
56477-56477 (1 pages)
PDF File:
05-19179.pdf